Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Familial dyskeratotic comedones are a rare, inherited skin condition that is hard to treat but may improve slightly with topical retinoids and urea cream.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Switching from escitalopram to duloxetine improved hair loss.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Flutamide reduces hair growth better but has more side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Stopping fluvoxamine can reverse hair loss caused by the drug.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.